Cargando…

Recent infective endocarditis research findings suggest dentists prescribe prophylactic antibiotics for patients having a bicuspid aortic valve or mitral valve prolapse

BACKGROUND: The scientific validity of the European Society of Cardiology’s (ESC) infective endocarditis (IE) guidelines limiting provision of prophylactic antibiotics (AP) only to patients having cardiac anomalies (e.g., prosthetic valves) believed to place them at “high risk” of adverse events whe...

Descripción completa

Detalles Bibliográficos
Autores principales: Friedlander, Arthur H, Couto-Souza, Paulo H
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medicina Oral S.L. 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10635622/
https://www.ncbi.nlm.nih.gov/pubmed/37330961
http://dx.doi.org/10.4317/medoral.25984
_version_ 1785146344364572672
author Friedlander, Arthur H
Couto-Souza, Paulo H
author_facet Friedlander, Arthur H
Couto-Souza, Paulo H
author_sort Friedlander, Arthur H
collection PubMed
description BACKGROUND: The scientific validity of the European Society of Cardiology’s (ESC) infective endocarditis (IE) guidelines limiting provision of prophylactic antibiotics (AP) only to patients having cardiac anomalies (e.g., prosthetic valves) believed to place them at “high risk” of adverse events when undergoing high risk dental procedures (HRDP) is unclear. MATERIAL AND METHODS: A systematic review of studies conducted between 2017 and 2022 and catalogued in the PubMed database was undertaken to ascertain if this edict was associated with changes in IE incidence, development of infection in unprotected cardiac anomalies, developing infection and resultant adverse clinical outcomes. RESULTS: Retrieved were 19 published manuscripts, however of these, 16 were excluded because they did not bare upon the issues of concern. Among the three studies eligible for review were those in the Netherlands, Spain, and England. The results of the Dutch study denoted a significant increase in the incidence of IE cases over the projected historical trend (rate ratio: 1327, 95% CI 1.205-1.462; p<0.001) after the introduction of the ESC guidelines. The findings from the Spanish study evidenced the uniquely high in-hospital IE associated fatality rates suffered by patients having bicuspid aortic valves (BAV); 5.6% or mitral valve prolapse (MVP); 10%. The British study provided evidence that the incidence of fatal IE infection was significantly greater among an “intermediate risk” cohort of patients, (a group likely including those with BAC and MVP for which the ESC guidelines don’t recommend AP), than among “high risk” patients (P = 0.002). CONCLUSIONS: Patients having either a BAV or MVP are at significant risk of developing IE and suffering serious sequelae including death. The ESC guidelines must reclassify these specific cardiac anomalies into the “high risk” category so that AP are recognized as being needed prior to provision of HRDP. Key words:Infective endocarditis, antibiotic prophylactic, dentistry.
format Online
Article
Text
id pubmed-10635622
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Medicina Oral S.L.
record_format MEDLINE/PubMed
spelling pubmed-106356222023-11-15 Recent infective endocarditis research findings suggest dentists prescribe prophylactic antibiotics for patients having a bicuspid aortic valve or mitral valve prolapse Friedlander, Arthur H Couto-Souza, Paulo H Med Oral Patol Oral Cir Bucal Review BACKGROUND: The scientific validity of the European Society of Cardiology’s (ESC) infective endocarditis (IE) guidelines limiting provision of prophylactic antibiotics (AP) only to patients having cardiac anomalies (e.g., prosthetic valves) believed to place them at “high risk” of adverse events when undergoing high risk dental procedures (HRDP) is unclear. MATERIAL AND METHODS: A systematic review of studies conducted between 2017 and 2022 and catalogued in the PubMed database was undertaken to ascertain if this edict was associated with changes in IE incidence, development of infection in unprotected cardiac anomalies, developing infection and resultant adverse clinical outcomes. RESULTS: Retrieved were 19 published manuscripts, however of these, 16 were excluded because they did not bare upon the issues of concern. Among the three studies eligible for review were those in the Netherlands, Spain, and England. The results of the Dutch study denoted a significant increase in the incidence of IE cases over the projected historical trend (rate ratio: 1327, 95% CI 1.205-1.462; p<0.001) after the introduction of the ESC guidelines. The findings from the Spanish study evidenced the uniquely high in-hospital IE associated fatality rates suffered by patients having bicuspid aortic valves (BAV); 5.6% or mitral valve prolapse (MVP); 10%. The British study provided evidence that the incidence of fatal IE infection was significantly greater among an “intermediate risk” cohort of patients, (a group likely including those with BAC and MVP for which the ESC guidelines don’t recommend AP), than among “high risk” patients (P = 0.002). CONCLUSIONS: Patients having either a BAV or MVP are at significant risk of developing IE and suffering serious sequelae including death. The ESC guidelines must reclassify these specific cardiac anomalies into the “high risk” category so that AP are recognized as being needed prior to provision of HRDP. Key words:Infective endocarditis, antibiotic prophylactic, dentistry. Medicina Oral S.L. 2023-11 2023-06-18 /pmc/articles/PMC10635622/ /pubmed/37330961 http://dx.doi.org/10.4317/medoral.25984 Text en Copyright: © 2023 Medicina Oral S.L. https://creativecommons.org/licenses/by/2.5/This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Review
Friedlander, Arthur H
Couto-Souza, Paulo H
Recent infective endocarditis research findings suggest dentists prescribe prophylactic antibiotics for patients having a bicuspid aortic valve or mitral valve prolapse
title Recent infective endocarditis research findings suggest dentists prescribe prophylactic antibiotics for patients having a bicuspid aortic valve or mitral valve prolapse
title_full Recent infective endocarditis research findings suggest dentists prescribe prophylactic antibiotics for patients having a bicuspid aortic valve or mitral valve prolapse
title_fullStr Recent infective endocarditis research findings suggest dentists prescribe prophylactic antibiotics for patients having a bicuspid aortic valve or mitral valve prolapse
title_full_unstemmed Recent infective endocarditis research findings suggest dentists prescribe prophylactic antibiotics for patients having a bicuspid aortic valve or mitral valve prolapse
title_short Recent infective endocarditis research findings suggest dentists prescribe prophylactic antibiotics for patients having a bicuspid aortic valve or mitral valve prolapse
title_sort recent infective endocarditis research findings suggest dentists prescribe prophylactic antibiotics for patients having a bicuspid aortic valve or mitral valve prolapse
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10635622/
https://www.ncbi.nlm.nih.gov/pubmed/37330961
http://dx.doi.org/10.4317/medoral.25984
work_keys_str_mv AT friedlanderarthurh recentinfectiveendocarditisresearchfindingssuggestdentistsprescribeprophylacticantibioticsforpatientshavingabicuspidaorticvalveormitralvalveprolapse
AT coutosouzapauloh recentinfectiveendocarditisresearchfindingssuggestdentistsprescribeprophylacticantibioticsforpatientshavingabicuspidaorticvalveormitralvalveprolapse